Julie C. Holder
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism, Bladder and Urothelial Cancer Treatments, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids(2003)2,309 cited
- → Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription(2000)888 cited
- → Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.(1997)520 cited
- → PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer(2000)384 cited
- Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.(1998)
- → Peroxisome Proliferator-Activated Receptor (PPAR)-β/δ Stimulates Differentiation and Lipid Accumulation in Keratinocytes(2004)228 cited
- → Insulin activates protein kinase B, inhibits glycogen synthase kinase‐3 and activates glycogen synthase by rapamycin‐insensitive pathways in skeletal muscle and adipose tissue(1997)220 cited
- → Role of PPAR γ and EGFR signalling in the urothelial terminal differentiation programme(2004)167 cited
- → Differential Regulation of Adipocytokine mRNAs by Rosiglitazone in db/db Mice(2001)151 cited
- → Repeat Treatment of Obese Mice With BRL 49653, a New Potent Insulin Sensitizer, Enhances Insulin Action in White Adipocytes: Association With Increased Insulin Binding and Cell-Surface GLUT4 as Measured by Photoaffinity Labeling(1995)140 cited